|
Variables
|
Number (%)
|
Mean value
|
|---|
|
Age (years)
| |
57.7 ± 5.69
|
|
≥ 60
|
11 (39.3)
| |
|
< 60
|
17 (60.7)
| |
|
Sex
| | |
|
Male
|
8 (28.6)
| |
|
Female
|
20 (71.4)
| |
|
Smoking status
| | |
|
Current and former
|
8 (28.6)
| |
|
Never
|
20 (71.4)
| |
|
Family history of tumor
| | |
|
Yes
|
5 (17.9)
| |
|
No
|
23 (82.1)
| |
|
Comorbidity
| | |
|
Yes
|
11 (39.3)
| |
|
No
|
17 (60.7)
| |
|
Preoperative CEA level
| |
3.38 ± 1.38
|
|
≥ 5.0 ng/ml
|
3 (10.7)
| |
|
< 5.0 ng/ml
|
25 (89.3)
| |
|
Ejection fraction
| |
61.16 ± 4.02
|
|
≥ 60
|
16 (57.1)
| |
|
55–59
|
12 (42.9)
| |
|
FEV1(L)
| |
2.68 ± 0.42
|
|
p-FEV1%
| |
96.95 ± 24.16
|
|
≥ 100
|
8 (28.6)
| |
|
80–100
|
10 (35.7)
| |
|
≤ 80
|
10 (35.7)
| |
|
Distribution of tumors
| | |
|
Unilateral
|
24 (85.7)
| |
|
Bilateral
|
4 (14.3)
| |
|
Number of tumors
| | |
|
3
|
20 (71.4)
| |
|
4
|
5 (17.9)
| |
|
5
|
3 (10.7)
| |
|
Highest pT
| | |
|
T1
|
26 (92.9)
| |
|
T2
|
2 (7.1)
| |
|
Highest pN
| | |
|
N0
|
27 (96.4)
| |
|
N1-2
|
1 (3.6)
| |
|
Adjuvant chemotherapy
| | |
|
Yes
|
1 (3.6)
| |
|
No
|
27 (96.4)
| |
